Leiters Partners with Hibernation Therapeutics to Provide Adenocaine™ Cardioplegic Solution
Leiters, a trusted FDA-registered 503B provider of high-quality compounded sterile preparations, announced today that it has entered into a national agreement with Hibernation Therapeutics to provide a patented cardioplegic solution developed by Hibernation Therapeutics known as Adenocaine™.
